SpaRx: elucidate single-cell spatial heterogeneity of drug responses for personalized treatment
Briefings in Bioinformatics · 22.09.2023 · 24 (6)
DOI: 10.1093/bib/bbad338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 05.10.2023. Verfasst von Ziyang Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer and Information Technology, Purdue University, Indiana, USA. Hauptthemen laut MEDLINE: Ecosystem, Precision Medicine. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NLM NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Spatial cellular authors heterogeneity contributes to differential drug responses in a tumor lesion and potential therapeutic resistance. Recent emerging spatial technologies such as CosMx, MERSCOPE and Xenium delineate the spatial gene expression patterns at the single cell resolution. This provides unprecedented opportunities to identify spatially localized cellular resistance and to optimize the treatment for individual patients. In this work, we present a graph-based domain adaptation model, SpaRx, to reveal the heterogeneity of spatial cellular response to drugs. SpaRx transfers the knowledge from pharmacogenomics profiles to single-cell spatial transcriptomics data, through hybrid learning with dynamic adversarial adaption. Comprehensive benchmarking demonstrates the superior and robust performance of SpaRx at different dropout rates, noise levels and transcriptomics coverage. Further application of SpaRx to the state-of-the-art single-cell spatial transcriptomics data reveals that tumor cells in different locations of a tumor lesion present heterogenous sensitivity or resistance to drugs. Moreover, resistant tumor cells interact with themselves or the surrounding constituents to form an ecosystem for drug resistance. Collectively, SpaRx characterizes the spatial therapeutic variability, unveils the molecular mechanisms underpinning drug resistance and identifies personalized drug targets and effective drug combinations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer and Information Technology, Purdue University, Indiana, USA.
- Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indiana, USA.
- Department of Computer Graphics Technology, Purdue University, Indiana, USA.
- Department of Statistics, Purdue University, Indiana, USA.
- Department of Cancer Biology, Wake Forest University School of Medicine, North Carolina, USA.
- Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Florida, USA.
Förderung
- NCI NIH HHS
- NLM NIH HHS
- NIGMS NIH HHS
- Comprehensive Cancer Center of Wake Forest University Health Sciences
- National Institute of General Medical Sciences
- National Institutes of Health
- Indiana University Precision Health Initiative
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Zitieren
APA
Tang, Z., Liu, X., Li, Z., Zhang, T., Yang, B., Su, J., & Song, Q. (2023). SpaRx: elucidate single-cell spatial heterogeneity of drug responses for personalized treatment. Briefings in Bioinformatics, 24(6). https://doi.org/10.1093/bib/bbad338
Vancouver
Tang Z, Liu X, Li Z, Zhang T, Yang B, Su J, et al. SpaRx: elucidate single-cell spatial heterogeneity of drug responses for personalized treatment. Briefings in Bioinformatics. 2023;24(6). doi:10.1093/bib/bbad338
BibTeX
@article{Tang2023,
author = {Tang, Ziyang and Liu, Xiang and Li, Zuotian and Zhang, Tonglin and Yang, Baijian and Su, Jing and Song, Qianqian},
title = {SpaRx: elucidate single-cell spatial heterogeneity of drug responses for personalized treatment},
journal = {Briefings in Bioinformatics},
year = {2023},
volume = {24},
number = {6},
doi = {10.1093/bib/bbad338}
}
EUVIMED